Skip to content
NeoVC
Pricing
All profiles
Accelerator

SF500

SF500 is an accelerator and VC fund investing in synbio companies from LATAM, that tackle human and planet preservation global challenges.

Rosario, ArgentinaFounded 2022

Is this your organization? Claim the profile to complete it and control what is public.

Claim this profile

Portfolio companies

23+

Investments

23+

Team

1-10

Founded

2022

Funds and vehicles

Members only

Assets under management

Members only

About

SF500 is a BioTech accelerator and VC fund. Founded in 2022. We turn science projects into Biotech startups. We search for outstanding science ideas and strong scientific and business people to build successful teams. We run a 12-week intensive program for 15 candidates with focus on science, team and product. A selection of the participants of our program receive a pre-seed investment of $200k. Our in-house dedicated portfolio management team keeps working with the founders, supporting all our portfolio startups from investment to the next stages. From legal and IP services to peer-to-peer support, lab facilities and connections to our network of international investors.

From public sources. The team can correct any field by claiming the profile.

Investment focus

Stages

Early Stage VentureSeed

Sectors

Advanced MaterialsAgricultureBiotechnologyFood and BeverageHealth DiagnosticsLife ScienceTherapeuticsVenture Capital

Investment thesis

Available to NeoVC members.

Founders and team

Team details are available to NeoVC members.

Portfolio

23+ portfolio companies on record

Company names are available to NeoVC members.

Founder, fund manager or LP?

Create a free account to see full profiles across the directory.

Your organization? Claim it to

  • Edit every field and publish your thesis
  • Show your funds, vehicles and AUM to LPs
  • List your portfolio and your team
  • Get found by founders and LPs on NeoVC

This profile was generated from public sources and may be incomplete. Claim it to correct it, or request removal.

SF500 | NeoVC